| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Pesticides & Agrochemicals
|
Compare with Industry peers |
| Website | http://www.indiapesticideslimited.com | |
| Market Cap | 2,585.42 Cr. | |
| Enterprise Value(EV) | 2,526.04 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 12.49 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | 18.06 | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 20.84 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 61.40 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 3.67 | Calculated using Price: 225.50 |
| Dividend Yield | 0.33 | Period Ending 2022-03 |
| No. of Shares Subscribed | 11.52 Cr. | 115,163,508 Shares |
| FaceValue | 1 | |
| Company Profile | ||
| The company has two distinct operating verticals, namely, Technicals; and Formulations. The company manufacture generic Technicals that are used in the manufacture of fungicides and herbicides as well as APIs with applications in dermatological products. It also manufacture and sell various formulations of insecticides, fungicide and herbicides, growth regulators and Acaricides, which are ready-to-use products. | ||
| 1 Day |
|
-1.57% |
| 1 Week |
|
-2.72% |
| 1 Month |
|
-9.51% |
| 3 Month |
|
-13.78% |
| 6 Month |
|
-21.32% |
| 1 Year |
|
-27.81% |
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 2 years | 2021-03 | 2022-03 | |
| Return on Equity (%) | 34.54 | 30.75 | |
| Return on Capital Employed (%) | 43.68 | 40.75 | |
| Return on Assets (%) | 23.97 | 22.46 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 389 | 638 | 707 | |
| Non Curr. Liab. | 16 | 21 | 19 | |
| Curr. Liab. | 155 | 187 | 194 | |
| Minority Int. | ||||
| Equity & Liab. | 561 | 845 | 920 | |
| Non Curr. Assets | 149 | 242 | 271 | |
| Curr. Assets | 412 | 604 | 650 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 561 | 845 | 920 |
| Particulars | 3 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 649 | 716 | 864 | |
| Other Income | 6 | 13 | 14 | |
| Total Income | 655 | 729 | 879 | |
| Total Expenditure | -466 | -502 | -667 | |
| PBIDT | 190 | 227 | 212 | |
| Interest | -3 | -7 | -10 | |
| Depreciation | -6 | -9 | -11 | |
| Taxation | -45 | -54 | -47 | |
| Exceptional Items | ||||
| PAT | 135 | 158 | 144 | |
| Minority Interest | ||||
| Share Associate | ||||
| Other Related Items | ||||
| Consolidated Net Profit | 135 | 158 | 144 | |
| Adjusted EPS | 12 | 14 | 12 |
| Particulars | 2 years | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 83 | 76 | |
| Cash Fr. Inv. | -83 | -133 | |
| Cash Fr. Finan. | -4 | 71 | |
| Net Change | -4 | 14 | |
| Cash & Cash Eqvt | 3 | 16 |
|
Sat, 04 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. on 04.02.2023 inter-alia has transacted the following items of business:1. Considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2022.2. Board has primarily considered the proposal of Employee Stock Option Scheme 2023 and recommended Nomination & Remuneration Committee to formulate detailed terms & conditions for ESOP 2023 but this shall not be construed as approval of scheme of ESOP. |
|
Sat, 04 Feb 2023
Outcome Of Board Meeting we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. on 04.02.2023 inter-alia to considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31 2022. |
|
Thu, 02 Feb 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 (6) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Company has scheduled Earnings Conference Call with Analysts/ Investors for Q3 and 9M FY 23 on Monday 06th February 2023 at 03:30 P.M. (I.S.T) in connection with Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine Month ended December 31 2022. |
| Fri, 03 Feb 2023 |
Close Crossing Last Week Low
|
Close Crossing Last Month Low
|
Closing Below Previous Low
|
Close Within 52 Week Low Zone
|
Close Below Last Week Low
|
Equities
M.F.
Sectors